Improvements in the prevention and management of infectious complications after hematopoietic stem cell transplantation.
Gea-Banacloche
Juan C
JC
Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. banacloj@mail.nih.gov
Wade
James C
JC
D001228:Aspergillosis / Q000209:etiology; D001424:Bacterial Infections / Q000150:complications / Q000209:etiology; D003141:Communicable Diseases / Q000150:complications; D024881:Drug Resistance, Bacterial; D005334:Fever; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods*; D006801:Humans; D007107:Immune System; D008495:Medical Oncology / Q000379:methods; D009181:Mycoses / Q000209:etiology; D009503:Neutropenia / Q000382:microbiology; D011008:Pneumococcal Infections / Q000150:complications / Q000276:immunology; D014640:Vancomycin / Q000494:pharmacology
D014640:Vancomycin